These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 19184056

  • 1. Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia.
    Honsawek S, Chaiwatanarat T, Vejchapipat P, Chongsrisawat V, Thawornsuk N, Poovorawan Y.
    Pediatr Surg Int; 2009 Mar; 25(3):261-7. PubMed ID: 19184056
    [Abstract] [Full Text] [Related]

  • 2. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K.
    Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure.
    Shaarawy M, Fathy SA, Mehany NL, Hindy OW.
    Clin Chem Lab Med; 2007 Apr; 45(11):1498-503. PubMed ID: 17970704
    [Abstract] [Full Text] [Related]

  • 4. Circulating leptin levels and bone mineral density in children with biliary atresia.
    Honsawek S, Chaiwatanarat T, Chongsrisawat V, Thawornsuk N, Vejchapipat P, Poovorawan Y.
    Acta Paediatr; 2008 Feb; 97(2):206-11. PubMed ID: 18177445
    [Abstract] [Full Text] [Related]

  • 5. Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease.
    Monegal A, Navasa M, Peris P, Alvarez L, Pons F, Rodés J, Guañabens N.
    Liver Int; 2007 May; 27(4):492-7. PubMed ID: 17403189
    [Abstract] [Full Text] [Related]

  • 6. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I, Larijani B, Vahdat K, Assadi M, Jafari SM, Ahmadi E, Movahed A, Moradhaseli F, Sanjdideh Z, Obeidi N, Amiri Z.
    Menopause; 2009 May; 16(5):950-5. PubMed ID: 19387415
    [Abstract] [Full Text] [Related]

  • 7. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
    Xu S, Wang Y, Lu J, Xu J.
    Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
    [Abstract] [Full Text] [Related]

  • 8. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, De la Vega-Prieto MJ, Milena-Abril A, Sánchez-Pérez MJ, Martínez-Riera A, Gómez-Rodríguez Mde L.
    Alcohol Alcohol; 2006 Nov; 41(3):261-6. PubMed ID: 16476762
    [Abstract] [Full Text] [Related]

  • 9. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.
    Rouster-Stevens KA, Langman CB, Price HE, Seshadri R, Shore RM, Abbott K, Pachman LM.
    Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075
    [Abstract] [Full Text] [Related]

  • 10. Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.
    Ali R, Hammad A, El-Nahrery E, Hamdy N, Elhawary AK, Eid R.
    Lupus; 2019 Sep; 28(10):1233-1242. PubMed ID: 31403902
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms.
    Eid R, Abdelsalam M, Fathy AA, Abolenein HM, Elmarghany EB, El-Hanafy AA, Hamdy N, Abd-Elmagid DS, Niazy NA, Abd-El Ghaffar DM.
    Pediatr Rheumatol Online J; 2023 Jun 16; 21(1):58. PubMed ID: 37328895
    [Abstract] [Full Text] [Related]

  • 12. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y, Onouchi T, Ikeda T, Adachi J, Tamura Y, Horiuchi T.
    Gerontology; 2009 Jun 16; 55(3):275-80. PubMed ID: 19158438
    [Abstract] [Full Text] [Related]

  • 13. The RANKL/OPG system and bone mineral density in patients with chronic liver disease.
    Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, Mühllechner P, Habior A, Graziadei I, Vogel W, Tilg H.
    J Hepatol; 2005 Dec 16; 43(6):973-83. PubMed ID: 16143421
    [Abstract] [Full Text] [Related]

  • 14. Increased serum sclerostin in postoperative biliary atresia.
    Honsawek S, Udomsinprasert W, Chaiwatanarat T, Vejchapipat P, Chongsrisawat V, Poovorawan Y.
    Clin Chim Acta; 2015 Mar 10; 442():136-40. PubMed ID: 25659290
    [Abstract] [Full Text] [Related]

  • 15. Changes in serum RANKL and OPG with sexual development and their associations with bone turnover and bone mineral density in a cohort of girls.
    Lucas R, Ramos E, Prata M, Rodrigues AM, Costa L, Severo M, Canhão H, Fonseca JE, Barros H.
    Clin Biochem; 2014 Aug 10; 47(12):1040-6. PubMed ID: 24769277
    [Abstract] [Full Text] [Related]

  • 16. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women.
    Zhao HY, Liu JM, Ning G, Zhao YJ, Chen Y, Sun LH, Zhang LZ, Xu MY, Chen JL.
    Osteoporos Int; 2008 Feb 10; 19(2):221-6. PubMed ID: 17703270
    [Abstract] [Full Text] [Related]

  • 17. Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis.
    Mansour A, Aboeerad M, Qorbani M, Hashemi Taheri AP, Pajouhi M, Keshtkar AA, Larijani B, Mohajeri-Tehrani MR, Ganji MR.
    BMC Nephrol; 2018 Jul 11; 19(1):172. PubMed ID: 29996796
    [Abstract] [Full Text] [Related]

  • 18. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men.
    Roshandel D, Holliday KL, Pye SR, Boonen S, Borghs H, Vanderschueren D, Huhtaniemi IT, Adams JE, Ward KA, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC, Thomson W, O'Neill TW, EMAS Study Group.
    J Bone Miner Res; 2010 Aug 11; 25(8):1830-8. PubMed ID: 20205168
    [Abstract] [Full Text] [Related]

  • 19. Maintained malnutrition produces a progressive decrease in (OPG)/RANKL ratio and leptin levels in patients with anorexia nervosa.
    Muñoz-Calvo MT, Barrios V, García de Alvaro MT, Lefort M, Méndez-Dávila C, Argente J, de la Piedra C.
    Scand J Clin Lab Invest; 2007 Aug 11; 67(4):387-93. PubMed ID: 17558893
    [Abstract] [Full Text] [Related]

  • 20. Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study.
    Jørgensen L, Vik A, Emaus N, Brox J, Hansen JB, Mathiesen E, Vestergaard P.
    Osteoporos Int; 2010 Jun 11; 21(6):931-8. PubMed ID: 19701599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.